Borealis Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Borealis Biosciences's total funding is $180M.
Employee Data
- Borealis Biosciences has 33 Employees.
- Borealis Biosciences grew their employee count by 3200% last year.
Borealis Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Head Research | Reveal Email/Phone |
4 | Head Reseach | Reveal Email/Phone |
5 | Associate Director, Discovery Biology | Reveal Email/Phone |
6 | Director, Business Development | Reveal Email/Phone |
7 | Executive Director, Translational Systems Biology and Data Sciences | Reveal Email/Phone |
8 | Director, Chemistry and DMPK | Reveal Email/Phone |
9 | Senior Director, Translation Biology and Strategic Alignment | Reveal Email/Phone |
10 | Scientist I | Reveal Email/Phone |
Borealis Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 48 | -9% | N/A | N/A |
#10 | $16.1M | 88 | 4% | N/A | N/A |
What Is Borealis Biosciences?
Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
keywords:N/A$180M
Total Funding
33
Number of Employees
N/A
Revenue (est)
3200%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.4M | 33 | -6% | N/A |
#2 | $6M | 33 | 18% | N/A |
#3 | $4.8M | 33 | 32% | N/A |
#4 | $4.9M | 33 | -3% | N/A |
#5 | $11.6M | 33 | -3% | N/A |